AI-powered contentSome parts of this article are powered by AI.
Share this article
Summary
Coal India unit Mahanadi Coalfields set a ₹129 to ₹136 price band for its ₹8,981.12 crore IPO, open November 19 to 23, per Angel One.
Johnson & Johnson (JNJ) is in talks to buy Ollin Biosciences for up to $3.4 billion, including $2.2 billion upfront, Reuters reported, citing the Financial Times.
MTN re-entered early-stage talks that could lead to an offer for all of Telkom's shares, with no certainty of a deal, Business Day reported.
Gotrade News - In IPO news for Monday, November 16, Coal India unit Mahanadi Coalfields set a ₹129 to ₹136 price band for its ₹8,981.12 crore offering, per Angel One, while Johnson & Johnson (JNJ) is in talks to buy Ollin Biosciences for up to $3.4 billion, Reuters reported, citing the Financial Times.
Separately, South Africa's MTN Group said it had re-entered discussions that could lead to an offer for all of Telkom's shares, according to Business Day. Both companies described the talks as early-stage, with no certainty that a transaction will follow.
Regular-session close on November 13, 2026, New York time. Prices and changes: Yahoo Finance, cross-checked against the closing price on Nasdaq.com. Market cap: that close times the shares outstanding on the latest 10-Q or 10-K cover (SEC EDGAR).
Mahanadi Coalfields (MCL) shares are scheduled to list on the BSE and NSE on November 27, after subscription runs from November 19 to 23, according to Angel One. The initial public offering is entirely an offer for sale by parent Coal India Limited, covering 66.18 crore equity shares.
The terms and schedule below are as reported by Angel One.
Term
Mahanadi Coalfields IPO
Price band
₹129 to ₹136 per share
Issue size
₹8,981.12 crore
Shares offered
66.18 crore, offer for sale by Coal India
Lot size
110 shares (₹14,960 at the upper band)
Anchor bidding
November 18, 2026
Subscription
November 19 to 23, 2026
Allotment (tentative)
November 25, 2026
Listing
November 27, 2026, BSE and NSE
What Is Mahanadi Coalfields Worth?
At the upper end of the price band, MCL's post-listing market capitalization would be about ₹90,009.74 crore, Angel One reported. The offer reserves 50% of shares for qualified institutional buyers, 35% for retail investors and 15% for non-institutional investors, with SBI Capital Markets as book running lead manager.
J&J would pay Ollin's backers $2.2 billion in cash upfront plus up to $1.2 billion in potential milestone payments, for a total of up to $3.4 billion, as reported by Reuters, citing the Financial Times and people familiar with the matter. The FT said J&J could announce the deal as soon as Monday.
Texas-based Ollin raised $330 million in June to advance late-stage studies of OLN324, its experimental eye drug for diabetic macular edema and wet age-related macular degeneration, per the same Reuters report. Reuters could not immediately verify the FT report, and neither J&J nor Ollin responded to requests for comment.
The talks follow J&J's $1 billion cash purchase of Firefly Bio earlier this year to expand its cancer pipeline, and its $14.6 billion acquisition of Intra-Cellular Therapies in 2025 to strengthen its neurology business, according to Reuters.
What Is MTN Offering Telkom Shareholders?
No price has been set. MTN said the consideration is currently contemplated to be cash, with an alternative for Telkom shareholders to receive MTN shares, and that "the terms of any transaction, including the form of consideration, remain subject to negotiation," according to Business Day.
MTN is valued at R427.7 billion on the JSE, against R31.7 billion for Telkom, Business Day reported. Both companies advised shareholders to exercise caution when trading their shares until a further announcement is made.
The talks revive a long-running pursuit. The two companies abandoned a network-sharing and commercial cooperation plan in 2015 over regulatory and antitrust concerns, and MTN walked away from takeover talks in October 2022 after Telkom could not provide exclusivity assurances, per Business Day.
This article is for education and information only and is not investment advice. Investment decisions are yours to make after your own research.
Gotrade is the trading name of Gotrade Securities Inc., which is registered with and supervised by the Labuan Financial Services Authority (LFSA). This content is for educational purposes only and does not constitute financial advice. Always do your own research (DYOR) before investing.
M. Alfathan Rahman is a content writer with over 3 years of experience developing digital content strategies across various industries, including fintech. He has experience producing content for tax-related websites and financial education platforms. His focus areas include data research, and crafting financial articles that are informative, accurate, and accessible to investors of all experience levels.
Hendrie Saputra holds a Master of Business Administration (MBA) with a concentration in Business Risk & Finance, along with professional experience in finance, marketing, and project management. He is experienced in analyzing market data and developing research-driven business strategies.